SQI Diagnostics reported that its sales were down in the fourth quarter of fiscal year 2021 and cited changes in the leadership team as one of the contributing factors.
For the fourth quarter of 2021, sales were $0.1 million compared to $0.3 million in the fourth quarter of fiscal year 2020. According to the company, the decrease was driven mainly by a reduction in Rali-Dx IL-6 Severity Triage Test kit sales, which accounted for the majority of sales in the prior year quarter.
Looking at fiscal 2021 as whole, sales were $0.9 million compared to $1 million in 2020.
